Read about how iPSC-derived cells can enhance your drug development research by offering a physiologically relevant model that can represent a disease population enabling research in many different stages of the development pipeline.

This white paper includes examples where iPSC-derived cells have been used in target identification, target validation, lead optimisation, and safety testing in order to reduce failure rates of drug candidates.

Download our white paper and discover how hiPSCs are an invaluable tool in drug discovery.